Joseph A. DiMasi

Best Publications

• The price of innovation: new estimates of drug development costs

  Joseph A. DiMasi;Ronald W. Hansen;Henry G. Grabowski

  6402
  Citations

• Innovation in the pharmaceutical industry: New estimates of R&D costs

  Joseph A. DiMasi;Henry G. Grabowski;Ronald W. Hansen

  3552
  Citations

• Cost of innovation in the pharmaceutical industry.

  Joseph A DiMasi;Ronald W Hansen;Henry G Grabowski;Louis Lasagna

  1164
  Citations

• Trends in Risks Associated With New Drug Development: Success Rates for Investigational Drugs

  J A DiMasi;L Feldman;A Seckler;A Wilson

  1048
  Citations

• The cost of biopharmaceutical R&D: is biotech different?

  Joseph A. DiMasi;Henry G. Grabowski

  843
  Citations

• Risks in new drug development: approval success rates for investigational drugs.

  Joseph A. DiMasi

  619
  Citations

• Economics of New Oncology Drug Development

  Joseph A. DiMasi;Henry G. Grabowski

  451
  Citations

• Returns on Research and Development for 1990s New Drug Introductions

  Henry Grabowski;John Vernon;Joseph A. DiMasi

  443
  Citations

• Pharmaceutical Innovation in the 21st Century: New Drug Approvals in the First Decade, 2000–2009

  KI Kaitin;JA DiMasi

  433
  Citations

• New drug development in the United States from 1963 to 1999.

  Joseph A. DiMasi

  326
  Citations

• The value of improving the productivity of the drug development process: faster times and better decisions.

  Joseph A. DiMasi

  309
  Citations

• Success rates for new drugs entering clinical testing in the United States

  Joseph A. DiMasi

  245
  Citations

• The economics of follow-on drug research and development

  Joseph A. DiMasi;Cherie Paquette

  236
  Citations

• Clinical Approval Success Rates for Investigational Cancer Drugs

  J A DiMasi;J M Reichert;L Feldman;A Malins

  230
  Citations

• Assessing the Financial Value of Patient Engagement: A Quantitative Approach from CTTI's Patient Groups and Clinical Trials Project.

  Bennett Levitan;Kenneth Getz;Eric L. Eisenstein;Michelle Goldberg

  161
  Citations

• Research and development costs for new drugs by therapeutic category. A study of the US pharmaceutical industry.

  Joseph A. DiMasi;Ronald W. Hansen;Henry C. Grabowski;Louis Lasagna

  159
  Citations

• R&D Costs and Returns by Therapeutic Category

  Joseph A DiMasi;Henry G Grabowski;John M Vernon

  151
  Citations

• The economics of follow-on drug research and development: trends in entry rates and the timing of development.

  Joseph A. DiMasi;Cherie Paquette

  146
  Citations

• The Cost of Drug Development

  Joseph A DiMasi;Henry G Grabowski;Ronald W Hansen

  142
  Citations

• Drug development costs when financial risk is measured using the Fama–French three‐factor model

  John A. Vernon;John A. Vernon;Joseph H. Golec;Joseph A. Dimasi

  134
  Citations